SE400472B - Forfarande for framstellning av en antihypertensiv komposition - Google Patents
Forfarande for framstellning av en antihypertensiv kompositionInfo
- Publication number
- SE400472B SE400472B SE7302895A SE7302895A SE400472B SE 400472 B SE400472 B SE 400472B SE 7302895 A SE7302895 A SE 7302895A SE 7302895 A SE7302895 A SE 7302895A SE 400472 B SE400472 B SE 400472B
- Authority
- SE
- Sweden
- Prior art keywords
- preparing
- procedure
- antihypertensive composition
- antihypertensive
- composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US00232294A US3833727A (en) | 1972-03-06 | 1972-03-06 | Hydralazine and beta-adrenergic blocking agent compositions for treating hypertension |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE400472B true SE400472B (sv) | 1978-04-03 |
Family
ID=22872572
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7302895A SE400472B (sv) | 1972-03-06 | 1973-03-01 | Forfarande for framstellning av en antihypertensiv komposition |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US3833727A (xx) |
| AT (1) | AT331966B (xx) |
| BE (1) | BE796288A (xx) |
| CA (1) | CA1015662A (xx) |
| CY (1) | CY951A (xx) |
| DD (1) | DD103559A5 (xx) |
| FR (1) | FR2181786B1 (xx) |
| GB (1) | GB1385648A (xx) |
| HK (1) | HK23378A (xx) |
| HU (1) | HU165714B (xx) |
| IE (1) | IE37326B1 (xx) |
| IL (1) | IL41610A (xx) |
| KE (1) | KE2839A (xx) |
| LU (1) | LU67144A1 (xx) |
| MY (1) | MY7800295A (xx) |
| NL (1) | NL176746C (xx) |
| PH (1) | PH18901A (xx) |
| SE (1) | SE400472B (xx) |
| ZA (1) | ZA731505B (xx) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4001421A (en) * | 1971-10-27 | 1977-01-04 | Syntex (U.S.A.) Inc. | Thiazole cardiovascular agents |
| AU540656B2 (en) * | 1980-02-19 | 1984-11-29 | Merck & Co., Inc. | S-(-)-1-(tert-butylamino-3((4-morpholino-1,2,5-thiadiazol-3- yl)-oxy)-2-propanol pamoate |
| US4521414A (en) * | 1981-06-18 | 1985-06-04 | The Texas A&M University System | Ophthalmic compositions and their use for treating elevated intraocular pressure and glaucoma |
| US20110092507A1 (en) * | 2009-10-20 | 2011-04-21 | Chin-Tsai Fan | Process for preparing R-(+)-3-morpholino-4-(3- tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazole |
-
1972
- 1972-03-06 US US00232294A patent/US3833727A/en not_active Expired - Lifetime
-
1973
- 1973-02-26 IL IL41610A patent/IL41610A/xx unknown
- 1973-02-27 CA CA164,752A patent/CA1015662A/en not_active Expired
- 1973-02-27 NL NLAANVRAGE7302728,A patent/NL176746C/xx not_active IP Right Cessation
- 1973-02-27 IE IE303/73A patent/IE37326B1/xx unknown
- 1973-03-01 GB GB997973A patent/GB1385648A/en not_active Expired
- 1973-03-01 CY CY951A patent/CY951A/xx unknown
- 1973-03-01 SE SE7302895A patent/SE400472B/xx unknown
- 1973-03-02 LU LU67144A patent/LU67144A1/xx unknown
- 1973-03-05 HU HUME1610A patent/HU165714B/hu unknown
- 1973-03-05 PH PH14393A patent/PH18901A/en unknown
- 1973-03-05 ZA ZA731505A patent/ZA731505B/xx unknown
- 1973-03-05 BE BE128383A patent/BE796288A/xx not_active IP Right Cessation
- 1973-03-05 DD DD169223A patent/DD103559A5/xx unknown
- 1973-03-06 FR FR7307877A patent/FR2181786B1/fr not_active Expired
- 1973-03-06 AT AT195873A patent/AT331966B/de not_active IP Right Cessation
-
1978
- 1978-05-04 HK HK233/78A patent/HK23378A/xx unknown
- 1978-05-15 KE KE2839A patent/KE2839A/xx unknown
- 1978-12-30 MY MY295/78A patent/MY7800295A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK23378A (en) | 1978-05-12 |
| AU5266273A (en) | 1974-08-29 |
| IL41610A (en) | 1975-08-31 |
| IL41610A0 (en) | 1973-04-30 |
| NL176746B (nl) | 1985-01-02 |
| DD103559A5 (xx) | 1974-02-05 |
| ATA195873A (de) | 1975-12-15 |
| PH18901A (en) | 1985-10-30 |
| BE796288A (fr) | 1973-09-05 |
| MY7800295A (en) | 1978-12-31 |
| IE37326B1 (en) | 1977-06-22 |
| IE37326L (en) | 1973-09-06 |
| CY951A (en) | 1978-12-22 |
| LU67144A1 (xx) | 1973-09-06 |
| AT331966B (de) | 1976-09-10 |
| NL176746C (nl) | 1985-06-03 |
| DE2310836B2 (de) | 1976-11-04 |
| FR2181786B1 (xx) | 1976-05-14 |
| US3833727A (en) | 1974-09-03 |
| ZA731505B (en) | 1974-10-30 |
| DE2310836A1 (de) | 1973-09-20 |
| FR2181786A1 (xx) | 1973-12-07 |
| NL7302728A (xx) | 1973-09-10 |
| CA1015662A (en) | 1977-08-16 |
| HU165714B (xx) | 1974-10-28 |
| KE2839A (en) | 1978-05-26 |
| GB1385648A (en) | 1975-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE404019B (sv) | Forfarande for framstellnig av n-fosfonometylglycin | |
| SE382059B (sv) | Forfarande for framstellning av nya substituerade piperidinderivat | |
| SE400771B (sv) | Forfarande for framstellning av 3alfa-hydroxi- och 3alfa-hydroxi-19-norpregnaner | |
| SE413246B (sv) | Forfarande for framstellning av kolesteroloxidas | |
| NO140731C (no) | Fremgangsmaate for fremstilling av dimetyleter | |
| SE417968B (sv) | Forfarande for framstellning av penamderivat | |
| SE419339B (sv) | Forfarande for framstellning av substituerade sulfonylacetamidocefalosporiner | |
| SE397530B (sv) | Forfarande for framstellning av 1-pyrazolylalkyl-4-arylpiperazinderivat | |
| NO139124C (no) | Fremgangsmaate for fremstilling av estere | |
| SE382053B (sv) | Forfarande for framstellning av bifenylylalkanoylaminopyridiner | |
| SE383151B (sv) | Forfarande for framstellning av 1-hydroxi-2-pyridoner | |
| SE423540B (sv) | Forfarande for framstellning av vissa 13-tiaprostaglandiner | |
| SE7611202L (sv) | Forfarande for framstellning av pyrazolodiazepinforeningar | |
| FI55626C (fi) | Anordning foer framstaellning av en behaollare | |
| NO139130C (no) | Fremgangsmaate til fremstilling av 2-alkylamino-dihydropyridiner | |
| SE387344B (sv) | Forfarande for framstellning av pyrazin-4-oxidderivat | |
| SE397088B (sv) | Forfarande for framstellning av nya 2-propanolderivat | |
| SE380272B (sv) | Forfarande for framstellning av n-fosfonmetylglycin | |
| SE385581B (sv) | Forfarande for framstellning av foretrade n-metylolkarbamidforeningar | |
| SE384510B (sv) | Forfarande for framstellning av nya isoindolinpiperazinderivat | |
| FI56830B (fi) | Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider | |
| SE402454B (sv) | Forfarande for framstellning av 2-alkoxi-5-alkylsulfonyl-toluen | |
| SE400472B (sv) | Forfarande for framstellning av en antihypertensiv komposition | |
| DK135944C (da) | Fremgangsmade til fremstilling af indolderivater | |
| FI53452C (fi) | Foerfarande foer framstaellning av n-laegre-alkyl-1,4-dihydro-4-oxokinolin-3-karboxylsyror |